Literature DB >> 15660290

Multiple avascular necrosis in a patient with systemic lupus erythematosus/systemic sclerosis overlap syndrome.

Javier Alberto Cavallasca1, Hugo Armando Laborde, Mariela Beatriz Araujo, Gustavo Guillermo Nasswetter.   

Abstract

A white female patient developed overlapping features of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) with severe pulmonary compromise. She was treated with steroids and azathioprine, which improved her clinical condition and spirometric status. In May 2002 she presented with continuous pain in her left ankle that continued even during rest and under treatment with nonsteroidal anti-inflammatory drugs (NSAIDs). Magnetic resonance imaging (MRI) showed multiple avascular necrosis (AVN). Rest and kinesitherapy were indicated for 1 year, and gradually an orthosis was introduced allowing the patient to walk normally.

Entities:  

Mesh:

Year:  2005        PMID: 15660290     DOI: 10.1007/s10067-004-1048-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Unusual overlap of systemic lupus erythematosus and diffuse scleroderma.

Authors:  C C Mok; J C Cheung; Y K Yee; M L Szeto
Journal:  Clin Exp Rheumatol       Date:  2001 Jan-Feb       Impact factor: 4.473

2.  Avascular necrosis of bone in systemic sclerosis.

Authors:  E Martinez-Cordero
Journal:  Clin Rheumatol       Date:  1992-09       Impact factor: 2.980

3.  Systemic scleroderma, A clinical study of 727 cases.

Authors:  D L TUFFANELLI; R K WINKELMANN
Journal:  Arch Dermatol       Date:  1961-09

4.  Multifocal ischemic necrosis of bone in scleroderma.

Authors:  V Fossaluzza; A Peressini; S De Vita
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

Review 5.  Scleroderma overlap syndromes.

Authors:  Janet E Pope
Journal:  Curr Opin Rheumatol       Date:  2002-11       Impact factor: 5.006

Review 6.  Pathogenesis and natural history of osteonecrosis.

Authors:  Yehudith Assouline-Dayan; Christopher Chang; Adam Greenspan; Yehuda Shoenfeld; M Eric Gershwin
Journal:  Semin Arthritis Rheum       Date:  2002-10       Impact factor: 5.532

Review 7.  Renal crisis in asclerodermic scleroderma--lupus overlap syndrome.

Authors:  H C Horn; P Ottosen; P Junker
Journal:  Lupus       Date:  2001       Impact factor: 2.911

8.  Multiple osteonecrotic lesions in systemic lupus erythematosus.

Authors:  B Fishel; D Caspi; I Eventov; E Avrahami; M Yaron
Journal:  J Rheumatol       Date:  1987-06       Impact factor: 4.666

9.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

10.  Osteonecrosis at multiple sites in a patient with systemic lupus erythematosus.

Authors:  L G Darlington
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

View more
  5 in total

Review 1.  Avascular necrosis in systemic sclerosis patients: a case-based review of demographics, presentation, and management.

Authors:  Bikash Basyal; Binita Bhandari; Chris T Derk
Journal:  Clin Rheumatol       Date:  2020-07-09       Impact factor: 2.980

Review 2.  Does vasculitis alone cause AVN? A review of literature.

Authors:  Rtika R Abraham; John O Meyerhoff
Journal:  Rheumatol Int       Date:  2012-08-03       Impact factor: 2.631

Review 3.  Multifocal osteonecrosis in systemic lupus erythematosus: case report and review of the literature.

Authors:  Luis D Fajardo-Hermosillo; Linnette López-López; Anaida Nadal; Luis M Vilá
Journal:  BMJ Case Rep       Date:  2013-04-16

4.  [Unclear hip pain in systemic sclerosis. Osteonecrosis].

Authors:  M Buslau; D Spitzenberger
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

5.  Next Generation Sequencing identifies mutations in GNPTG gene as a cause of familial form of scleroderma-like disease.

Authors:  Abdelali Zrhidri; Saadia Amasdl; Jaber Lyahyai; Hanane Elouardi; Bouchra Chkirate; Laure Raymond; Grégory Egéa; Mohamed Taoudi; Said El Mouatassim; Abdelaziz Sefiani
Journal:  Pediatr Rheumatol Online J       Date:  2017-09-26       Impact factor: 3.054

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.